Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Microsoft Kinect, Gait Function,Hemineglect, Vestibulo-ocular Training

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03913663
Recruitment Status : Completed
First Posted : April 12, 2019
Last Update Posted : July 24, 2019
Sponsor:
Information provided by (Responsible Party):
Mohammed Youssef Elhamrawy, Beni-Suef University

Brief Summary:
Gait problems in hemineglect patient post stroke , vestibuloocular training plays a role in improving gait function, gait assessment using a model based study (Microsoft Kinect) for pre and post training assesment.

Condition or disease Intervention/treatment Phase
Hemiplegic Gait Other: vestibuloocular training Other: regular exercise training for hemiplegic patients Not Applicable

Detailed Description:
The syndrome of visuospatial neglect is a common consequence of unilateral brain injury. It is most often associated with stroke and is more severe and persistent following right hemisphere damage, with reported frequencies in the acute stage of up to 80%. This may result in gait disturbance, high levels of energy expenditure and increase the risk of falls. Vestibuleo-ocular training techniques are aimed at improving or even restoring visual function by training patients to detect stimuli in the blind hemifield and increase their overall sensitivity to them. The investigators propose a model based (Microsoft Kinect), a device can be used for assessment of spatiotemporal gait variables as well as gait kinematics.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: A Model Based Study for Gait in Heminglect Patient Pre and Post Vestibul-ocular Rehabilitation
Actual Study Start Date : May 22, 2019
Actual Primary Completion Date : July 15, 2019
Actual Study Completion Date : July 18, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Active Comparator: study group
20 patient with hemineglect, minimum 6 months post stroke
Other: vestibuloocular training
using vestibulo ocular training program for training neglect patient
Other Name: regular exercise training for hemiplegic patients

Other: regular exercise training for hemiplegic patients
Traditional gait training program.

Active Comparator: control group
20 patient with hemineglect, minimum 6 months post stroke
Other: regular exercise training for hemiplegic patients
Traditional gait training program.




Primary Outcome Measures :
  1. gait changes in hemineglect patient after vestibulo ocular rehabilitation program [ Time Frame: baseline ]
    gait assesment using microsoft kinect for hemineglect patient pre and post vestibulo ocular rehabilitation



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects age will range from (60-70) years old.
  • Patients who had a stroke at least six months prior.
  • Patients who had visual field defects post stroke.
  • Patients who could walk without caretaker assistance or no severe dyskinesias.
  • Adequate hearing (hearing aid if required).
  • Patients who had no problem with their state of consciousness and absence of dementia
  • Patients who had no orthopedic problems that may affect gait.
  • Patients will be chosen in both sexes.
  • Clinically and medically stable.

Exclusion Criteria:

Patients who will meet one of the following criteria will be excluded from the study:

  • Only one functional eye.
  • Neurological problem or any severe co-morbidity likely to affect gait.
  • Intact visual field.
  • Instability of patient's medical condition.
  • Obese ( BMI ≥ 30 Kg∕m2 ).
  • Association with another medical problem that can affect patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03913663


Locations
Layout table for location information
Egypt
Beni Suef University
Banī Suwayf, Beni Suef, Egypt, 62511
Sponsors and Collaborators
Beni-Suef University
Investigators
Layout table for investigator information
Principal Investigator: mohammed elhamrawy, master Beni-Suef University

Publications:
Layout table for additonal information
Responsible Party: Mohammed Youssef Elhamrawy, dr, Beni-Suef University
ClinicalTrials.gov Identifier: NCT03913663     History of Changes
Other Study ID Numbers: microsoft kinect hemineglect
First Posted: April 12, 2019    Key Record Dates
Last Update Posted: July 24, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Gait Disorders, Neurologic
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms